Bukwang's Lebovir received grand prix in new drug development.

Published: 2007-03-05 06:56:00

Updated: 2007-03-05 06:56:00

Lebovir, the 11th Korean new drug developed by Bukwang with 110 billion won of investment during the past 12 years from its preclinical, clinical, synthesis and dosage form
research and development received the grand prix in the occasion of the general congress of the Korean Drug Research Assoc...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK